Changing landscapes and increasing relevance of immunotherapy in localized MSI-H gastric adenocarcinoma DOI Creative Commons
Jane E. Rogers, Jaffer A. Ajani

Expert Review of Clinical Pharmacology, Год журнала: 2024, Номер unknown, С. 1 - 2

Опубликована: Дек. 9, 2024

KEYWORDS: Gastric neoplasmsimmunotherapymicrosatellite instability highdeficient mismatch repairimmune checkpoint therapy

Язык: Английский

JOURNAL OF SURGICAL RESEARCH DOI Open Access

Anthony Allsbrook,

Jennifer To,

Odessa R. Pulido

и другие.

Journal of Surgical Research, Год журнала: 2024, Номер 296, С. iv - x

Опубликована: Март 16, 2024

Язык: Английский

Процитировано

0

A New Medical Evaluation for Gastric Cancer Patients to Increase the Success Rate of Immunotherapy: A 2024 Update DOI Creative Commons
Gabriel Samaşcă, Claudia Burz,

Irena Pintea

и другие.

Pharmaceuticals, Год журнала: 2024, Номер 17(9), С. 1121 - 1121

Опубликована: Авг. 24, 2024

Researchers have performed numerous studies on immunotherapy because of the high death rate associated with gastric cancer (GC). GC research has made tremendous progress, and we wanted to provide an update this topic. On basis update, suggest performing a new medical evaluation before initiating in patients increase success immunotherapies. We propose that start immunotherapy, they should be evaluated given score one two points for following factors: immunopathological features, molecular genomic potential consequences bacterial pathogens, immunotherapeutic resistance hyperprogressive illness, use biomarkers gauge their prognosis responses optimize surgery. The proposed scoring system could also help diagnosis GC. With all advances genetics, immunology, microbiology, improved, not changed. Currently, diagnosed undergo surgical resection as only permanent solution. Patients who meet maximum from presented proposal eligible immediately after immunotherapy. Therefore, first-line option clinicians.

Язык: Английский

Процитировано

0

Changing landscapes and increasing relevance of immunotherapy in localized MSI-H gastric adenocarcinoma DOI Creative Commons
Jane E. Rogers, Jaffer A. Ajani

Expert Review of Clinical Pharmacology, Год журнала: 2024, Номер unknown, С. 1 - 2

Опубликована: Дек. 9, 2024

KEYWORDS: Gastric neoplasmsimmunotherapymicrosatellite instability highdeficient mismatch repairimmune checkpoint therapy

Язык: Английский

Процитировано

0